<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - VACCINES</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drugClass/">Drug classes</a></li>
      </ul>

      <h1>VACCINES</h1>

      <nav>
        <ul class="nav nav-list">

          <li><a href="#pregnancy" data-toggle="tab">Pregnancy</a></li>
          <li><a href="#contraindications" data-toggle="tab">Contra indications</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#directionsForAdministration" data-toggle="tab">Administration</a></li>
          <li><a href="#cautions" data-toggle="tab">Cautions</a></li>
          <li><a href="#handlingAndStorage" data-toggle="tab">Handling and storage</a></li>
          <li><a href="#allergyAndCrossSensitivity" data-toggle="tab">Allergy and cross sensitivity</a></li>
          <li><a href="#drugsInClass" data-toggle="tab">Drugs in class</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">



      <section class="tab-pane" id="pregnancy">
        <h2>Advice when patient is pregnant</h2>

            <section class="generalInformation">
              <p>Live vaccines should not be administered routinely to pregnant women because of the theoretical risk of fetal infection but where there is a significant risk of exposure to disease, the need for vaccination usually outweighs any possible risk to the fetus. Termination of pregnancy following inadvertent immunisation is not recommended. There is no evidence of risk from vaccinating pregnant women with inactivated viral or bacterial vaccines or toxoids.</p>
            </section>
      </section>



      <section class="tab-pane" id="contraindications">
        <h2>Contra indications</h2>

      </section>

      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

          <h3>General side effects</h3>
              <p>
                <strong>commonOrVeryCommon:</strong> Fatigue, fever, gastro-intestinal disturbances, headache, irritability, loss of appetite, lymphangitis, malaise, myalgia,
              </p>
              <p>
                <strong>veryRare:</strong> Anaphylaxis (can be fatal), angioedema (can be fatal), bronchospasm (can be fatal), hypersensitivity reactions (can be fatal), urticaria (can be fatal),
              </p>
              <p>
                <strong>notKnown:</strong> Arthralgia, asthenia, dizziness, drowsiness, influenza-like symptoms, lymphadenopathy, paraesthesia, rash,
              </p>
        
          <h3>Specific side effects</h3>
              <p>
                <strong>commonOrVeryCommon:</strong> induration may develop at the injection site, inflammation, local reactions, pain, redness, sterile abscess may develop at the injection site, induration may develop at the injection site, inflammation, local reactions, pain, redness, sterile abscess may develop at the injection site, induration may develop at the injection site, inflammation, local reactions, pain, redness, sterile abscess may develop at the injection site,
              </p>
        
            <section class="advice">
              <p>Occasionally serious adverse reactions can occur&#8212;these should always be reported to the CHM.</p>
            </section>
            <section class="advice">
                <h3>Post-immunisation pyrexia in infants</h3>
              <p>The parent should be advised that if pyrexia develops after childhood immunisation, and the infant seems distressed, paracetamol can be given. Ibuprofen can be used if paracetamol is unsuitable. The parent should be warned to seek medical advice if the pyrexia persists.</p>
            </section>
        
      </section>

      <section class="tab-pane" id="directionsForAdministration">
        <h2>Directions for administration</h2>

            <section class="directionsForAdministration">
              <p>If alcohol or disinfectant is used for cleansing the skin it should be allowed to evaporate before vaccination to prevent possible inactivation of live vaccines.</p>
            </section>
            <section class="directionsForAdministration">
              <p>When 2 or more live vaccines are required (and are not available as a combined preparation), they can be administered at any time before or after each other at different sites, preferably in a different limb; if more than one injection is to be given in the same limb, they should be administered at least 2.5&#8239;cm apart.</p>
            </section>
            <section class="directionsForAdministration">
              <p>Vaccines should not be given intravenously. Most vaccines are given by the intramuscular route, although some are given by either the intradermal, deep subcutaneous, or oral route. The intramuscular route should not be used in patients with <b>bleeding disorders</b> such as haemophilia or thrombocytopenia, vaccines usually given by the intramuscular route should be given by deep subcutaneous injection instead.</p><p>The Department of Health has advised <i>against the use of jet guns </i> for vaccination owing to the risk of transmitting blood borne infections, such as HIV.</p>
            </section>
            <section class="directionsForAdministration">
              <p>Particular attention must be paid to instructions on the use of diluents. Vaccines which are liquid suspensions or are reconstituted before use should be adequately mixed to ensure uniformity of the material to be injected.</p>
            </section>
      </section>




      <section class="tab-pane" id="cautions">
        <h2>Cautions regarding administration</h2>

        <ul>
          <li>
            Acute illness
          </li>
          <li>
            minor illnesses
          </li>
        </ul>
        <ul>
          <li>
            <p>Vaccination may be postponed if the individual is suffering from an acute illness; however, it is not necessary to postpone immunisation in patients with minor illnesses without fever or systemic upset.</p>
          </li>
          <li>
            <p>Immune response to vaccines may be reduced in immunosuppressed patients and there is also a risk of generalised infection with live vaccines.</p><p>Specialist advice should be sought for those being treated with high doses of corticosteroids (dose equivalents of prednisolone: <b>adults</b>, at least 40&#8239;mg daily for more than 1 week; <b>children</b>, 2&#8239;mg/kg (or more than 40&#8239;mg) daily for at least 1 week or 1&#8239;mg/ kg daily for 1 month), or other immunosuppressive drugs, and those being treated for malignant conditions with chemotherapy or generalised radiotherapy. Live vaccines should be postponed until at least 3 months after stopping high-dose systemic corticosteroids and at least 6 months after stopping other immunosuppressive drugs or generalised radiotherapy (at least 12 months after discontinuing immunosuppressants following bone-marrow transplantation).</p><p>The Royal College of Paediatrics and Child Health has produced a statement, <i>Immunisation of the Immunocompromised Child (2002)</i> (available at <xref format="html" href="http://www.rcpch.ac.uk">www.rcpch.ac.uk</xref>).</p>
          </li>
          <li>
            <p>When there is a personal or family history of <i>febrile</i> convulsions, there is an increased risk of these occurring during fever from any cause including immunisation, but this is not a contra-indication to immunisation. In children who have had a seizure associated with fever without neurological deterioration, immunisation is <i>recommended</i>; advice on the <i>management of fever</i> (see Post-immunisation Pyrexia in Infants) should be given before immunisation. When a child has had a convulsion not associated with fever, and the neurological condition is not deteriorating, immunisation is <i>recommended</i>.</p><p>Children with stable neurological disorders (e.g. spina bifida, congenital brain abnormality, and peri-natal hypoxic-ischaemic encephalopathy) should be immunised according to the recommended schedule.</p><p>When there is a <i>still evolving neurological problem</i>, including poorly controlled epilepsy, immunisation should be deferred and the child referred to a specialist. Immunisation is recommended if a cause for the neurological disorder is identified. If a cause is not identified, immunisation should be deferred until the condition is stable.</p>
          </li>
        </ul>
      </section>






      <section class="tab-pane" id="handlingAndStorage">
        <h2>Advice regarding handling and storage</h2>

            <section class="handlingAndStorage">
              <p>Care must be taken to store all vaccines under the conditions recommended in the product literature, otherwise the preparation may become ineffective. <b>Refrigerated storage</b> is usually necessary; many vaccines need to be stored at 2&#8211;8&#176;C and not allowed to freeze. Vaccines should be protected from light. Reconstituted vaccines and opened multidose vials must be used within the period recommended in the product literature. Unused vaccines should be disposed of by incineration at a registered disposal contractor.</p>
            </section>
      </section>






      <section class="tab-pane" id="allergyAndCrossSensitivity">
        <h2>Advice regarding allergies and cross sensitivities</h2>

            <section class="contraindications">
              <p>Contra-indicated in patients with a confirmed anaphylactic reaction to a preceding dose of a vaccine containing the same antigens or vaccine component (such as antibacterials in viral vaccines).</p>
            </section>
        
      </section>

      <section class="tab-pane" id="drugsInClass">
        <h2>Drugs in the class of VACCINES</h2>

          <ul>
            <li><a href="../drug/PHP8245.html">ANTHRAX VACCINE</a></li>
            <li><a href="../drug/PHP8249.html">BACILLUS CALMETTE-GU&amp;#201;RIN VACCINE</a></li>
            <li><a href="../drug/PHP8260.html">CHOLERA VACCINE</a></li>
            <li><a href="../drug/PHP8291.html">HEPATITIS A VACCINE</a></li>
            <li><a href="../drug/PHP8310.html">HEPATITIS B VACCINE</a></li>
            <li><a href="../drug/PHP8317.html">HUMAN PAPILLOMAVIRUS VACCINES</a></li>
            <li><a href="../drug/PHP8321.html">INFLUENZA VACCINE</a></li>
            <li><a href="../drug/PHP8340.html">JAPANESE ENCEPHALITIS VACCINE</a></li>
            <li><a href="../drug/PHP8349.html">MEASLES, MUMPS AND RUBELLA VACCINE, LIVE</a></li>
            <li><a href="../drug/PHP8373.html">PNEUMOCOCCAL VACCINE</a></li>
            <li><a href="../drug/PHP8391.html">RABIES VACCINE</a></li>
            <li><a href="../drug/PHP8396.html">ROTAVIRUS VACCINE</a></li>
            <li><a href="../drug/PHP8407.html">TICK-BORNE ENCEPHALITIS VACCINE, INACTIVATED</a></li>
            <li><a href="../drug/PHP8411.html">TYPHOID VACCINE</a></li>
            <li><a href="../drug/PHP8420.html">VARICELLA-ZOSTER VACCINE</a></li>
            <li><a href="../drug/PHP8427.html">YELLOW FEVER VACCINE, LIVE</a></li>
            <li><a href="../drug/PHP88117.html">DIPHTHERIA WITH HAEMOPHILUS INFLUENZAE TYPE B VACCINE, PERTUSSIS, POLIOMYELITIS AND TETANUS</a></li>
            <li><a href="../drug/PHP88118.html">DIPHTHERIA WITH PERTUSSIS, POLIOMYELITIS VACCINE AND TETANUS</a></li>
            <li><a href="../drug/PHP88119.html">DIPHTHERIA WITH POLIOMYELITIS AND TETANUS VACCINE</a></li>
            <li><a href="../drug/PHP88120.html">HAEMOPHILUS INFLUENZAE TYPE B WITH MENINGOCOCCAL GROUP C VACCINE</a></li>
            <li><a href="../drug/PHP88125.html">MENINGOCOCCAL GROUPS A WITH C AND W135 AND Y VACCINE</a></li>
            <li><a href="../drug/PHP88126.html">MENINGOCOCCAL GROUP B VACCINE (RDNA, COMPONENT, ADSORBED)</a></li>
            <li><a href="../drug/PHP99985.html">MENINGOCOCCAL GROUP C VACCINE</a></li>
          </ul>
      </section>

    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
</body>
</html>
